-
公开(公告)号:US09242987B2
公开(公告)日:2016-01-26
申请号:US13503083
申请日:2010-10-19
申请人: Nigel Ramsden , Richard John Harrison , Sally Oxenford , Kathryn Bell , Nelly Piton , Claudio Dagostin , Cyrille Broussard , Andrew Ratcliffe
发明人: Nigel Ramsden , Richard John Harrison , Sally Oxenford , Kathryn Bell , Nelly Piton , Claudio Dagostin , Cyrille Broussard , Andrew Ratcliffe
IPC分类号: C07D487/04 , A61K31/519 , A61P29/00 , A61P37/00 , A61P37/08 , A61P41/00 , A61K31/541 , A61K31/5386 , A61K31/5377 , A61K31/496
CPC分类号: C07D487/04
摘要: The invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
摘要翻译: 本发明涉及式(I)的化合物,其中X 1至X 5,Y,Z 1至Z 3和R具有在说明书和权利要求书中引用的含义。 所述化合物可用作JAK抑制剂,用于治疗或预防免疫学,炎症,自身免疫,过敏性疾病和免疫介导的疾病。 本发明还涉及包含所述化合物的药物组合物,这些化合物的制备以及作为药物的用途。
-
公开(公告)号:US20120252779A1
公开(公告)日:2012-10-04
申请号:US13503083
申请日:2010-10-19
申请人: Nigel Ramsden , Richard John Harrison , Sally Oxenford , Kathryn Bell , Nelly Piton , Claudio Dagostin , Cyrille Boussard , Andrew Ratcliffe
发明人: Nigel Ramsden , Richard John Harrison , Sally Oxenford , Kathryn Bell , Nelly Piton , Claudio Dagostin , Cyrille Boussard , Andrew Ratcliffe
IPC分类号: A61K31/519 , A61K31/5386 , A61K31/5377 , A61K31/496 , A61P41/00 , C07D487/04 , A61P37/00 , A61P29/00 , A61P37/08 , A61K31/541 , C07D498/08
CPC分类号: C07D487/04
摘要: The invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
摘要翻译: 本发明涉及式(I)的化合物,其中X 1至X 5,Y,Z 1至Z 3和R具有在说明书和权利要求书中引用的含义。 所述化合物可用作JAK抑制剂,用于治疗或预防免疫学,炎症,自身免疫,过敏性疾病和免疫介导的疾病。 本发明还涉及包含所述化合物的药物组合物,这些化合物的制备以及作为药物的用途。
-
公开(公告)号:US20130131043A1
公开(公告)日:2013-05-23
申请号:US13642189
申请日:2011-04-18
IPC分类号: C07D487/04
CPC分类号: C07D487/04
摘要: The invention relates to compounds of formula (I) wherein R1, R2, R1a, R1b have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
摘要翻译: 本发明涉及式(I)化合物,其中R1,R2,R1a,R1b具有在说明书和权利要求书中引用的含义。 所述化合物可用作JAK抑制剂,用于治疗或预防免疫学,炎症,自身免疫,过敏性疾病和免疫介导的疾病。 本发明还涉及包含所述化合物的药物组合物,这些化合物的制备以及作为药物的用途。
-
4.
公开(公告)号:US07846929B2
公开(公告)日:2010-12-07
申请号:US11789427
申请日:2007-04-24
申请人: Adrian Folkes , Stephen Shuttleworth , Sally Oxenford , Tim Hancox , Tracy Bayliss , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Kimberly Malesky , Simon Mathieu , Alan Olivero , Daniel P. Sutherlin , Vickie Tsui , Shumei Wang , Christian Wiesmann , Bing-Yan Zhu , Jennafer Dotson
发明人: Adrian Folkes , Stephen Shuttleworth , Sally Oxenford , Tim Hancox , Tracy Bayliss , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Kimberly Malesky , Simon Mathieu , Alan Olivero , Daniel P. Sutherlin , Vickie Tsui , Shumei Wang , Christian Wiesmann , Bing-Yan Zhu , Jennafer Dotson
IPC分类号: A61K31/5377 , C07D413/14
CPC分类号: C07D491/04 , C07D495/04
摘要: Compounds of Formulas Ia and Ib, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
摘要翻译: 式Ia和Ib的化合物,并且包括立体异构体,几何异构体,互变异构体,溶剂合物,代谢物和药学上可接受的盐可用于抑制脂质激酶(包括PI3K)和用于治疗由脂质激酶介导的癌症等疾病。 公开了将式Ia和Ib化合物用于体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
公开(公告)号:US08383620B2
公开(公告)日:2013-02-26
申请号:US12978106
申请日:2010-12-23
申请人: Tracy Bayliss , Irina Chuckowree , Adrian Folkes , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Steven Staben , Daniel P. Sutherlin , Bing-Yan Zhu
发明人: Tracy Bayliss , Irina Chuckowree , Adrian Folkes , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Steven Staben , Daniel P. Sutherlin , Bing-Yan Zhu
IPC分类号: A61K31/535
CPC分类号: A61K31/5377 , A61K31/519 , C07D413/14 , C07D491/04 , C07D495/04
摘要: Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R3 is a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for modulating the activity of lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia-d for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
-
6.
公开(公告)号:US20110112085A1
公开(公告)日:2011-05-12
申请号:US13006217
申请日:2011-01-13
申请人: Georgette M. Castanedo , Janet L. Gunzner , Kimberly Malesky , Simon Mathieu , Alan G. Olivero , Daniel P. Sutherlin , Shumei Wang , Bing-Yan Zhu , Irina Chuckowree , Adrian Folkes , Sally Oxenford , Nan-Chi Wan
发明人: Georgette M. Castanedo , Janet L. Gunzner , Kimberly Malesky , Simon Mathieu , Alan G. Olivero , Daniel P. Sutherlin , Shumei Wang , Bing-Yan Zhu , Irina Chuckowree , Adrian Folkes , Sally Oxenford , Nan-Chi Wan
IPC分类号: A61K31/5377 , A61P35/00 , A61P35/02
CPC分类号: C07D513/04
摘要: Compounds of Formulas Ia and Ib, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
摘要翻译: 式Ia和Ib的化合物,并且包括立体异构体,几何异构体,互变异构体,溶剂合物,代谢物和药学上可接受的盐可用于抑制脂质激酶(包括PI3K)和用于治疗由脂质激酶介导的癌症等疾病。 公开了将式Ia和Ib化合物用于体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
公开(公告)号:US08802670B2
公开(公告)日:2014-08-12
申请号:US11789468
申请日:2007-04-24
申请人: Adrian Folkes , Stephen Shuttleworth , Irina Chuckowree , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Daniel P. Sutherlin , Bing-Yan Zhu
发明人: Adrian Folkes , Stephen Shuttleworth , Irina Chuckowree , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Daniel P. Sutherlin , Bing-Yan Zhu
IPC分类号: A61K31/535 , C07D413/14
CPC分类号: A61K31/5377 , A61K31/551 , A61K45/06 , C07D491/04 , C07D491/048 , C07D495/04
摘要: Compounds of Formulae Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
摘要翻译: 式Ia和Ib的化合物及其立体异构体,几何异构体,互变异构体,溶剂合物,代谢物和药学上可接受的盐可用于抑制脂质激酶(包括PI3K)和用于治疗由脂质激酶介导的癌症等疾病。 公开了将式Ia和Ib化合物用于体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
公开(公告)号:US20110105464A1
公开(公告)日:2011-05-05
申请号:US12916125
申请日:2010-10-29
申请人: Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Kimberly Malesky , Simon Mathieu , Alan Olivero , Daniel P. Sutherlin , Vickie Tsui , Shumei Wang , Christian Wiesmann , Bing-Yan Zhu , Jennafer Dotson , Adrian Folkes , Stephen Shuttleworth , Sally Oxenford , Tim Hancox , Tracy Bayliss
发明人: Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Kimberly Malesky , Simon Mathieu , Alan Olivero , Daniel P. Sutherlin , Vickie Tsui , Shumei Wang , Christian Wiesmann , Bing-Yan Zhu , Jennafer Dotson , Adrian Folkes , Stephen Shuttleworth , Sally Oxenford , Tim Hancox , Tracy Bayliss
CPC分类号: C07D491/04 , C07D495/04
摘要: Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
摘要翻译: 公开了将式Ia和Ib化合物用于体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
公开(公告)号:US20080242665A1
公开(公告)日:2008-10-02
申请号:US11951203
申请日:2007-12-05
申请人: Tracy Bayliss , Irina Chuckowree , Adrian Folkes , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Steven Staben , Daniel P. Sutherlin , Bing-Yan Zhu
发明人: Tracy Bayliss , Irina Chuckowree , Adrian Folkes , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Steven Staben , Daniel P. Sutherlin , Bing-Yan Zhu
IPC分类号: A61K31/5377 , C07D495/04 , A61P35/04
CPC分类号: A61K31/5377 , A61K31/519 , C07D413/14 , C07D491/04 , C07D495/04
摘要: Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R3 is a monocyclic heteroaryl group, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for modulating the activity of lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia-d for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
摘要翻译: 式Ia-d的化合物,其中X是S或O,mor是吗啉基团,R 3是单环杂芳基,并且包括立体异构体,几何异构体,互变异构体,溶剂合物,代谢物和药学上可接受的 其盐可用于调节脂质激酶(包括PI3K)的活性,以及用于治疗由脂质激酶介导的癌症等疾病。 公开了使用式Ia-d的化合物在体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
公开(公告)号:US20080076758A1
公开(公告)日:2008-03-27
申请号:US11789468
申请日:2007-04-24
申请人: Adrian Folkes , Stephen Shuttleworth , Irina Chuckowree , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Daniel Sutherlin , Bing-Yan Zhu
发明人: Adrian Folkes , Stephen Shuttleworth , Irina Chuckowree , Sally Oxenford , Nan Chi Wan , Georgette Castanedo , Richard Goldsmith , Janet Gunzner , Tim Heffron , Simon Mathieu , Alan Olivero , Daniel Sutherlin , Bing-Yan Zhu
IPC分类号: A61K31/5377 , A61K31/551 , A61P25/00 , A61P29/00 , A61P3/00 , A61P31/00 , A61P35/00 , A61P37/00 , A61P9/00 , C07D491/048 , C07D495/04
CPC分类号: A61K31/5377 , A61K31/551 , A61K45/06 , C07D491/04 , C07D491/048 , C07D495/04
摘要: Compounds of Formulae Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
摘要翻译: 式Ia和Ib的化合物及其立体异构体,几何异构体,互变异构体,溶剂合物,代谢物和药学上可接受的盐可用于抑制脂质激酶(包括PI3K)和用于治疗由脂质激酶介导的癌症等疾病。 公开了将式Ia和Ib化合物用于体外,原位和体内诊断,预防或治疗哺乳动物细胞或相关病理状况中的这种病症的方法。
-
-
-
-
-
-
-
-
-